#1 Clinical Trials Search in Europe
EU – Europe
AT – Austria
HR – Croatia
CZ – Czech Republic
DK – Denmark
EE – Estonia
FI – Finland
FR – France
DE – Germany
IS – Iceland
IT – Italy
LV – Latvia
LT – Lithuania
NL – Netherlands
NO – Norway
PL – Poland
PT – Portugal
RO – Romania
SK – Slovakia
SI – Slovenia
ES – Spain
SE – Sweden
  • Find a Clinical Trial

    Search Trials by Disease

    Non-small cell lung cancer Breast cancer Plasma cell myeloma Neoplasm Neoplasm malignant Acute myeloid leukaemia Colitis ulcerative Colorectal cancer metastatic Obesity Prostate cancer Crohn's disease Colorectal cancer Ovarian cancer Dementia Alzheimer's type Hepatocellular carcinoma Breast cancer metastatic Dermatitis atopic Asthma Non-small cell lung cancer metastatic Malignant melanoma More trials…
  • Rare Diseases Treatments

    Search Trials by Disease

    Depression Renal cell carcinoma Urea cycle disorder Chronic lymphocytic leukaemia Squamous cell carcinoma of head and neck Small cell lung cancer Hepatocellular carcinoma Ocular myasthenia Aspergillus infection Congenital leptin deficiency Bronchiolitis Rhabdomyosarcoma Astrocytoma Neuroendocrine carcinoma Gastrointestinal stromal tumour More trials…

    Learn about Rare Diseases

    Congenital nephrogenic diabetes insipidus – Basic Information Progressive supranuclear palsy – Treatment Niemann-Pick disease – Basic Information Marfan’s syndrome – Trials in Disease Mucopolysaccharidosis – Basic Information Glomerulonephritis membranous Adrenogenital syndrome – Life with Disease Ocular melanoma – Treatment Choroid melanoma Gaucher’s disease type III – Life with Disease More diseases
  • Vaccine Clinical Trials
  • Pediatric Clinical Trials
  • Resources for Patients

    Browse Innovative Treatments

    Edoxaban Temsirolimus Abc-16F-116 L-PHENYLALANINE Tisagenlecleucel Etifoxine Hydrochloride Fulvestrant Methoxsalen Pseudoephedrine Hydrochloride Soft Paraffin And Fat Products Selexipag VG801-1 Lutropin Alfa Tipranavir Salbutamol Sulfate VAMIFEPORT TRIHYDROCHLORIDE Ima402 Methadone Hydrochloride Eprosartan Mesilate Gtaexs617 More therapies…

    Learn about Your Condition

    Androgenetic alopecia Notalgia paraesthetica Prolymphocytic leukaemia Vascular malformation Procedural hypotension Arthroscopy Infant sedation Anaemia of chronic disease Procedural anxiety Premature baby Alpha-1 antitrypsin deficiency Cerebrovascular accident Primary hypercholesterolaemia Haemoglobinuria Tertiary adrenal insufficiency More diseases
  • Healthy Volunteers
  • Patient Guide
  • Our Partners
  • About Us
  • Contact us
  • Region
    🇪🇺 Europe
    🇦🇹 Austria
    🇭🇷 Croatia
    🇨🇿 Czech Republic
    🇩🇰 Denmark
    🇪🇪 Estonia
    🇫🇮 Finland
    🇫🇷 France
    🇩🇪 Germany
    🇮🇸 Iceland
    🇮🇹 Italy
    🇱🇻 Latvia
    🇱🇹 Lithuania
    🇳🇱 Netherlands
    🇳🇴 Norway
    🇵🇱 Poland
    🇵🇹 Portugal
    🇷🇴 Romania
    🇸🇰 Slovakia
    🇸🇮 Slovenia
    🇪🇸 Spain
    🇸🇪 Sweden

Nutritional and Metabolic Diseases

  • Study on the Safety and Effectiveness of Sodium Zirconium Cyclosilicate for Children with High Potassium Levels

    Recruiting

    3 1 1 1
    Investigated Drugs:
    • Sodium Zirconium Cyclosilicate
    Germany Poland Romania Spain

  • Study on Stiripentol for Patients Aged 6 and Older with Primary Hyperoxaluria Types 1, 2, or 3

    Recruiting

    3 1 1
    Investigated Drugs:
    • Stiripentol
    Belgium France Italy

  • Study on Tranexamic Acid and Sodium Chloride to Reduce Bleeding in Gastric Bypass Surgery for Patients with Severe Obesity

    Recruiting

    3 1 1
    Investigated Diseases:
    • Metabolic surgery
    • Obesity
    Investigated Drugs:
    • Tranexamic Acid
    • Sodium Chloride
    The Netherlands

  • Study on the Use of Plasma Rich in Growth Factors for Treating Foot Ulcers in Diabetic Patients with Peripheral Arterial Disease

    Recruiting

    3 1 1
    Investigated Diseases:
    • Diabetic foot
    Investigated Drugs:
    • Platelet Concentrate
    Spain

  • Study on the Effects of Empagliflozin, Pioglitazone, and Semaglutide for Patients with Type 2 Diabetes

    Recruiting

    2 1 1 1
    Investigated Diseases:
    • Diabetes mellitus
    • Type 2 diabetes mellitus
    Investigated Drugs:
    • Pioglitazone
    • Empagliflozin
    • Semaglutide
    Denmark Sweden

  • Long-Term Safety Study of GLM101 for Patients with PMM2-CDG

    Recruiting

    2 1 1
    Investigated Drugs:
    • M1P Dipotassium Salt
    Czechia France Germany Italy Portugal Spain
Previous Page
1 … 16 17 18 19 20 … 61
Next Page

Investigational Drugs in This Location

See which drug candidates are part of clinical trials near you. Click for detailed trial information.

Medical Conditions Being Studied in This Location

Explore diseases currently included in clinical trials near you. Click to view trials and details for each condition.

European Clinical Trials Information Network

The European Clinical Trials Information Network is transforming access to clinical trial information for patients across Europe. By overcoming language barriers, our platform allows everyone, regardless of their native language, to easily find relevant and comprehensible clinical trial data. This innovative service connects patients to cutting-edge treatments, creating a unified European community where health and progress transcend borders.

This service is not affiliated with the European Commission, the EMA, or the official CTIS system. Most information comes from publicly available international clinical-trial registries, supplemented by data from academic centres, national regulators, and commercial sponsors. We aim to keep all content accurate and up to date.

Explore the full ecosystem of clinical research in Europe.

The information provided on this website is mainly derived from international public clinical trial databases (CTIS.eu). In addition, we are including supplementary sources, such as information provided by academic centers and national regulators, as well as information supplied by commercial sponsors (pharmaceutical companies and contract research organizations). We try to ensure that the information provided is accurate and up to date.

Certain content and visual elements on this website have been generated or enhanced using artificial intelligence (AI).

The website is published by:
CTIN POLAND sp. z o.o.
with its registered office in Warsaw,
ul. rtm. Witolda Pileckiego 67/109,
02-781 Warsaw, Poland,
entered in the Register of Entrepreneurs of the National Court Register under KRS number 0001111334,
REGON: 528919042, NIP (Tax ID): 9512598637
Contact us

© 2026 CTIN Poland

Privacy Policy

Terms and Conditions

Contact

For Sites and Sponsors

Clinical Trial Locations

We use cookies

The website uses cookies to ensure the proper functioning of the site and to analyze internet traffic. Some cookies are essential for using the service and do not require consent. You can accept all cookies or use only the essential ones. Data is processed in accordance with our Privacy Policy. You have the right to withdraw your consent, access, rectify, delete, or limit the processing of your data at any time.
Numer nieprawidłowy!
Numer nieprawidłowy!